Analyst Ratings for Celldex Therapeutics (CLDX) [Neutrals]
CLDX Rating Summary
CLDX Price Target Summary
- Highest: $90.00 (Guggenheim)
- Lowest: $35.00 (Wells Fargo)
- Average: $65.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$65.40 (+55.8%)
* Over Last 12-Mos
Rating Score: 7.5 / 10 Percentile Rank: 80%
Rating Score: 7.5 / 10 Percentile Rank: 80%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/10/2023 | Wells Fargo » Updated 2/28/2024 |
Derek Archila | Upgrade | Equal Weight (Underweight) |
35.00 (27.00) |
25.78 (41.97) |
62.8% | Details |
3/8/2016 | Wedbush » Updated 5/9/2016 |
N/A | Downgrade | Neutral (Outperform) |
3.00 (4.00) |
3.79 (41.97) |
1007.39% | Details |